The Use of Cefepime for Treating AmpC β-Lactamase–Producing Enterobacteriaceae
Author:
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Microbiology (medical)
Link
http://academic.oup.com/cid/article-pdf/57/6/781/17853200/cit395.pdf
Reference45 articles.
1. AmpC beta-lactamases;Jacoby;Clin Microbiol Rev,2009
2. Risk factors and clinical features of infections caused by plasmid-mediated AmpC beta-lactamase-producing Enterobacteriaceae;Park;Int J Antimicrob Agents,2009
3. Clinical laboratory detection of AmpC beta-lactamase: does it affect patient outcome?;Rand;Am J Clin Pathol,2011
4. Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species;Cosgrove;Arch Intern Med,2002
5. Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae;Pai;Antimicrob Agents Chemother,2004
Cited by 134 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The impact of meropenem shortage and post-prescription review and feedback on broad-spectrum antimicrobial use: An interrupted time-series analysis;Infection Prevention in Practice;2024-09
2. Clinical Outcomes of Patients with AmpC-Beta-Lactamase-Producing Enterobacterales Bacteremia Treated with Carbapenems versus Non-Carbapenem Regimens: A Single-Center Study;Antibiotics;2024-07-29
3. Piperacillin/Tazobactam Susceptibility Test Interpretive Criteria for Enterobacterales: Recommendations From the United States Committee on Antimicrobial Susceptibility Testing;Clinical Infectious Diseases;2024-06-21
4. Potentielle Nephrotoxizität der Kombinationstherapie von Vancomycin und Piperacillin-Tazobactam: Empfehlungen der AG ABS der DGPI unter Beteiligung von Experten der GPN;Klinische Pädiatrie;2024-03-08
5. Evaluation of predictors of third-generation cephalosporin non-susceptibility and factors affecting recurrence or death in bacteremia caused by Citrobacter freundii complex , Enterobacter cloacae complex, and Klebsiella aerogenes;Journal of Chemotherapy;2024-03-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3